Search Results - "Rettenbacher, M."
-
1
Impact of childhood trauma on antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, semi-randomized trial
Published in Schizophrenia research (01-08-2022)“…Antipsychotic medications are generally effective in ameliorating psychotic symptoms in schizophrenia spectrum disorders (SSDs). Identifying predictors…”
Get full text
Journal Article -
2
Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial
Published in BMC psychiatry (29-06-2023)“…Antipsychotic treatment may improve clinical insight. However, previous studies have reported inconclusive findings on whether antipsychotics improve insight…”
Get full text
Journal Article -
3
Childhood trauma types in relation to antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, randomized controlled study
Published in Psychiatry research (01-11-2024)“…•Some patients with schizophrenia do not respond favorably to antipsychotics.•Childhood trauma types may influence antipsychotic effectiveness in…”
Get full text
Journal Article -
4
Symptomatic remission and neurocognitive functioning in patients with schizophrenia
Published in Psychological medicine (01-10-2011)“…A cross-sectional study was conducted in participants with schizophrenia to explore a potential association between the patients' remission status and…”
Get more information
Journal Article -
5
Metabolic side effects of antipsychotic medication
Published in International journal of clinical practice (Esher) (01-08-2007)“…The use of second-generation antipsychotics (SGAs) is associated with metabolic side effects including weight gain, diabetes mellitus and an atherogenic lipid…”
Get more information
Journal Article -
6
Does childhood trauma influence cognitive functioning in schizophrenia? The association of childhood trauma and cognition in schizophrenia spectrum disorders
Published in Schizophrenia research. Cognition (01-09-2020)“…Childhood trauma (CT) is a risk factor for schizophrenia spectrum disorders (SSDs), and cognitive impairment is a core feature and a vulnerability marker of…”
Get full text
Journal Article -
7
A multi-centre phase 3 study comparing efficacy and safety of Bemfola® versus Gonal-f® in women undergoing ovarian stimulation for IVF
Published in Reproductive biomedicine online (01-05-2015)“…Abstract Bemfola (follitropin alfa) (Finox AG, Switzerland), a new recombinant FSH, has a comparable pharmacological profile to that of Gonal-f (Merck Serono,…”
Get full text
Journal Article -
8
A multi-centre phase 3 study comparing efficacy and safety of Bemfola® versus Gonal-f® in women undergoing ovarian stimulation for IVF
Published in Reproduktivnaâ èndokrinologiâ (27-05-2021)“…Bemfola (follitropin alfa) (Finox AG, Switzerland), a new recombinant FSH, has a comparable pharmacological profile to that of Gonal-f (Merck Serono, Germany),…”
Get full text
Journal Article -
9
Neutropenia induced by second generation antipsychotics: a prospective investigation
Published in Pharmacopsychiatry (01-03-2010)“…Clozapine is known to induce neutropenia as well as agranulocytosis. Some cases of olanzapine- and risperidone-induced neutropenia and agranulocytosis have…”
Get more information
Journal Article -
10
Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia
Published in Acta Psychiatrica Scandinavica (01-11-2007)“…Objective: In this prospective study, patients with schizophrenia were followed up for 3 months to investigate the impact of sociodemographic factors,…”
Get full text
Journal Article -
11
Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective study
Published in Pharmacopsychiatry (01-01-2009)“…Due to the association of second generation antipsychotics (SGAs) with weight gain and alterations of glucose and lipid homeostasis, we aimed to group six…”
Get more information
Journal Article -
12
Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder
Published in European archives of psychiatry and clinical neuroscience (01-06-2006)“…Outcome in schizophrenia is multidimensional and, thus, consists of clinical,humanitarian, rehabilitative and cost domains. Accordingly, recovery is…”
Get full text
Journal Article -
13
Localization and characterization of neuropeptide receptors in human colon
Published in Naunyn-Schmiedeberg's archives of pharmacology (01-10-2001)“…Information about the expression of neuropeptide receptors is limited in human peripheral tissues, such as the gastrointestinal tract, as compared to the…”
Get full text
Journal Article -
14
Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine
Published in Pharmacopsychiatry (01-01-2007)“…We compared stable patients with schizophrenia who were treated with either amisulpride or olanzapine in terms of symptomatic outcome, neurocognitive…”
Get more information
Journal Article -
15
Childhood trauma in schizophrenia spectrum disorders as compared to substance abuse disorders
Published in Psychiatry research (01-03-2018)“…The prevalence of childhood trauma (CT) in schizophrenia spectrum disorders (SSDs) and substance abuse disorders (SUDs) is high. Direct comparisons of CT in…”
Get full text
Journal Article -
16
Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics
Published in The international journal of neuropsychopharmacology (01-03-2015)“…Nonadherence to medication is still a major problem in the treatment of schizophrenia. The current longitudinal study investigated whether the patients'…”
Get full text
Journal Article -
17
Session 29: Ovarian stimulation
Published in Human reproduction (Oxford) (01-06-2013)Get full text
Journal Article -
18
Compliance in schizophrenia: Psychopathology, Side effects, and patients' attitudes toward the illness and medication
Published in The journal of clinical psychiatry (01-09-2004)“…In a cross-sectional study, we investigated the influence of several factors on compliance in schizophrenia outpatients, including patients' attitudes toward…”
Get full text
Journal Article -
19
Prolactin Levels and Sexual Adverse Effects in Patients With Schizophrenia During Antipsychotic Treatment
Published in Journal of clinical psychopharmacology (01-12-2010)“…Patients with schizophrenia often experience sexual dysfunction (SD), to which disorder-related factors like negative symptoms and nondisorder-related factors…”
Get full text
Journal Article -
20
Osteoporosis in Patients With Schizophrenia
Published in The American journal of psychiatry (01-01-2005)“…OBJECTIVE: Osteoporosis is regularly mentioned as a possible consequence of treatment with prolactin-increasing antipsychotic medications, but little is known…”
Get full text
Journal Article